Excess costs of medical care for patients with diabetes in a managed care population

scientific article published in September 1997

Excess costs of medical care for patients with diabetes in a managed care population is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2337/DIACARE.20.9.1396
P698PubMed publication ID9283786
P5875ResearchGate publication ID13936730

P2093author name stringSelby JV
Zhang D
Ray GT
Colby CJ
P433issue9
P407language of work or nameEnglishQ1860
P304page(s)1396-1402
P577publication date1997-09-01
P1433published inDiabetes CareQ5270111
P1476titleExcess costs of medical care for patients with diabetes in a managed care population
P478volume20

Reverse relations

cites work (P2860)
Q57300406A Pre-Pregnancy Biomarker Risk Score Improves Prediction of Future Gestational Diabetes
Q43568866A Web-based diabetes care management support system
Q61837575A cohort study of maternal cardiometabolic risk factors and primary cesarean delivery in an integrated health system
Q31021002Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study
Q37396518Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population
Q88721293Acute Kidney Injury and Risk of Heart Failure and Atherosclerotic Events
Q35671644Advances in the treatment of the diabetic foot: Is there a role for adjunctive hyperbaric oxygen therapy?
Q36453704Alcohol consumption is inversely associated with adherence to diabetes self-care behaviours
Q44014706American Orthopaedic Foot and Ankle Society shoe survey of diabetic patients
Q36270263Are characteristics of the medical home associated with diabetes care costs?
Q33653519Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction
Q34259993CKD and the risk of incident cancer
Q34745500Cardiovascular disease prevention practices by U.S. Physicians for patients with diabetes
Q34353474Characteristics of coronary artery disease in symptomatic type 2 diabetic patients: evaluation with CT angiography
Q34724785Characteristics of insured patients with persistent gaps in diabetes care services: the Translating Research into Action for Diabetes (TRIAD) study
Q34718437Cohort study of pioglitazone and cancer incidence in patients with diabetes
Q34017377Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease.
Q36278140Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project.
Q50055734Contemporary Procedural Complications, Hospitalizations, and Emergency Visits After Catheter Ablation for Atrial Fibrillation
Q40607835Cost of diabetes-related complications: current issues, future directions
Q35660940Cost-of-illness studies in diabetes mellitus
Q41681284Costs of acid-related disorders to a health maintenance organization
Q40762705Current status and future prospects of parenteral insulin regimens, strategies and delivery systems for diabetes treatment
Q46900712Determining the Value of Disease Management Programs
Q48104054Diabetes and the occurrence of infection in primary care: a matched cohort study
Q37260160Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization
Q34808283Diabetes mellitus update.
Q35060223Diabetes performance measures: current status and future directions
Q44429435Diabetes prevalence based on health insurance claims: large differences between companies
Q34906314Diabetes trends in the USA.
Q30327334Diabetes--a common, growing, serious, costly, and potentially preventable public health problem.
Q64058482Diagnostic thresholds for pregnancy hyperglycemia, maternal weight status and the risk of childhood obesity in a diverse Northern California cohort using health care delivery system data
Q33773284Differences in resource use and costs of primary care in a large HMO according to physician specialty
Q35102218Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study
Q34024303Direct costs associated with chronic kidney disease among type 2 diabetic patients in India
Q31082713Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data
Q34269284Disparities in the risk of gestational diabetes by race-ethnicity and country of birth
Q34142209Doppler ultrasound detection of preclinical changes in foot arteries in early stage of type 2 diabetes.
Q36493505Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study
Q34020768Effectiveness of β-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease.
Q36624663Elevated BP after AKI.
Q33534641Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis
Q33506099Examining the economic costs related to lifestyle and pharmacological interventions in youth with Type 2 diabetes
Q74313845Excess costs of diabetes in the Aboriginal population of Manitoba, Canada
Q44190278Excess costs of medical care 1 and 8 years after diagnosis of diabetes: estimates from young and middle-aged incidence cohorts in Sweden
Q46136302Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
Q35776374Frequency, cost, and risk factors of readmissions among severe sepsis survivors
Q44946408Functional status before and after diagnosis of Type 2 diabetes
Q33511374Generational status and duration of residence predict diabetes prevalence among Latinos: the California Men's Health Study
Q34124052Glipizide. A review of the pharmacoeconomic implications of the extended-release formulation in type 2 diabetes mellitus
Q40561412Global policy: aspects of diabetes in India
Q36857207Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases
Q48634234Greater variability in kidney function is associated with an increased risk of death
Q43826500Health care utilization and costs in type 2 diabetes mellitus and their association with renal impairment
Q33751647Health systems, patients factors, and quality of care for diabetes: a synthesis of findings from the TRIAD study
Q22306347Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Q37435643Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Q31443172Identifying persons with diabetes using Medicare claims data
Q44276574Impact of primary care on hospitalization of type 2 diabetics with equal conditions of health insurance
Q34730228Improved blood pressure control associated with a large-scale hypertension program
Q89769327Improved insulin injection technique, treatment satisfaction and glycemic control: Results from a large cohort education study
Q34545338Incidence of remission in adults with type 2 diabetes: the diabetes & aging study
Q28384260Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study
Q44493907Incidence, prevalence and coronary heart disease risk level in known Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain
Q37388643Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting
Q90597568Long-Term Outcomes of Adults With Heart Failure by Left Ventricular Systolic Function Status
Q37657045Long-term survival after ischemic stroke in patients with atrial fibrillation
Q37331309Low prepregnancy adiponectin concentrations are associated with a marked increase in risk for development of gestational diabetes mellitus.
Q34437761Medical care and payment for diabetes in China: enormous threat and great opportunity.
Q38498048Medical costs of managed care in patients with type 2 diabetes mellitus
Q35046673Metformin use and lung cancer risk in patients with diabetes.
Q46381161Outcomes of Project Dulce: a culturally specific diabetes management program
Q50653724Patient-level estimates of the cost of complications in diabetes in a managed-care population.
Q33556884Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer
Q36570644Pioglitazone initiation and subsequent hospitalization for congestive heart failure
Q30730318Post-discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization
Q33975756Prediabetes and lifestyle modification: time to prevent a preventable disease
Q33793775Pregravid liver enzyme levels and risk of gestational diabetes mellitus during a subsequent pregnancy.
Q37057928Prepregnancy Adverse Lipid Profile and Subsequent Risk of Gestational Diabetes.
Q37715543Prepregnancy SHBG concentrations and risk for subsequently developing gestational diabetes mellitus
Q30991231Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany--a retrospective cohort and case control study in claims data of a large statutory health insurance
Q35799908Psychometric properties of the Greek Diabetes Treatment Satisfaction Questionnaire
Q42628486Recommendations of dietitians for overcoming barriers to dietary adherence in individuals with diabetes
Q37112121Refilling medications through an online patient portal: consistent improvements in adherence across racial/ethnic groups
Q35750497Regular screening in type 2 diabetes. A mnemonic approach for improving compliance, detecting complications
Q93348253Risk Factors for Recurrent Acute Kidney Injury in a Large Population-Based Cohort
Q35049079Risk of death and the economic accessibility at the dialysis therapy for the renal insufficient patients in Lubumbashi city, Democratic Republic of Congo
Q36107202Role of surgical revascularization in diabetic patients with coronary artery disease
Q43670630Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry
Q34421536Serial Glycosylated Hemoglobin Levels and Risk of Colorectal Neoplasia among Patients with Type 2 Diabetes Mellitus
Q36084025Sex ratio variations among the offspring of women with diabetes in pregnancy.
Q35494326Sickness absence in diabetic employees
Q35741754Slowing cardiovascular disease progression in African-American patients: diabetes management
Q35115553The Case for “Outsourcing” Diabetes Care
Q33802011The Nurse Education and Transition (NEAT) model: educating the hospitalized patient with diabetes
Q64910749The Value of Elderly Disease Prevention.
Q33723318The association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: the diabetes and aging study
Q50783147The cost burden of diabetes mellitus: the evidence from Germany--the CoDiM study.
Q41723442The cost of health conditions in a health maintenance organization
Q35099421The cost of major comorbidity in people with diabetes mellitus
Q50798130The joint impact of cardiovascular risk factors upon medical costs.
Q39669785The prevalence and cost of diabetes in metropolitan France: what trends between 1998 and 2000?*.
Q36608177The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente Northern California Diabetes Registry
Q31271125The use of automated data to identify complications and comorbidities of diabetes: a validation study
Q34743143The use of computerized birthday greeting reminders in the management of diabetes
Q37066317Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus
Q34683673Timing of hormone therapy and dementia: the critical window theory revisited
Q39280391Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in Northern California: 1996-2014.
Q38405209Trends in Incidence of Hospitalized Acute Myocardial Infarction in the Cardiovascular Research Network (CVRN).
Q34882597Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM project
Q37067102Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: A report from the Translating Research Into Action for Diabetes (TRIAD) Study.
Q42976561Type 2 diabetes mellitus and its complications: from the molecular biology to the clinical practice
Q38776019Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.
Q34732964Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes
Q34172425Use of medical services and medicines attributable to diabetes in Sub-Saharan Africa
Q36343894Use of medical services and medicines attributable to type 2 diabetes care in Yaoundé, Cameroon: a cross-sectional study
Q37734919Use of the refill function through an online patient portal is associated with improved adherence to statins in an integrated health system
Q41667228Using continuous quality improvement to improve diabetes care in populations: the IDEAL model. Improving care for Diabetics through Empowerment Active collaboration and Leadership
Q36757590Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease
Q79869902[The cost of complications: implications for the measurement of the cost of type II diabetes mellitus]

Search more.